Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
about
Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.A single-day treatment with mifepristone is sufficient to normalize chronic glucocorticoid induced suppression of hippocampal cell proliferation.CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.Mifepristone pretreatment reduces ethanol withdrawal severity in vivo.Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.The regulation of muscle mass by endogenous glucocorticoids.Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.Fluorescent ligand for human progesterone receptor imaging in live cells.Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.Estrous cycle phase and gonadal hormones influence conditioned fear extinction.Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids.Pharmacokinetics and metabolism of endothelin receptor antagonist: contribution of kidneys in the overall in vivo N-demethylation.Modulation of Rat 50-kHz Ultrasonic Vocalizations by Glucocorticoid Signaling: Possible Relevance to Reward and Motivation.Brief RU 38486 treatment normalizes the effects of chronic stress on calcium currents in rat hippocampal CA1 neurons.
P2860
Q30434638-9FBCE1A8-CB1E-442D-985A-56C60E3094AFQ31104566-A194154E-A9BA-4681-A62C-67AAF733F787Q34082581-268D1537-9AF3-437E-8225-ECA407B9B19DQ34199459-DB827B22-1754-438A-9655-2775C0D798D5Q34577581-27267568-A092-450D-AAC5-62634548A9BBQ35042169-7A5996E9-5EA7-4BF8-8AAA-DD0174F5EF6EQ35669093-E8D37559-A949-400E-850B-D8C15A0FF06FQ36857601-80C2D803-9E0C-49A8-A9A7-C37DF473CDBEQ37118756-F1A16F2F-E750-4900-A7EA-CF017E8092EAQ37440523-CA9291A8-EECD-4A8F-980D-F73F93E7C819Q37648657-E02617C3-4A2B-40C4-837C-18C7CB69FC39Q44303123-14EEAF94-EC6A-43F4-A615-21A5793B52B2Q47304750-01B30DD3-3C1A-46D6-B69C-F12A77011130Q48307801-20D6D98A-5FD3-43F7-BA79-690876D7D6A5
P2860
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@en
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@nl
type
label
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@en
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@nl
prefLabel
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@en
Hepatic metabolism and distribution of mifepristone and its metabolites in rats.
@nl
P2093
P356
P1433
P1476
Hepatic metabolism and distribution of mifepristone and its metabolites in rats
@en
P2093
O Heikinheimo
P Lähteenmäki
R Huupponen
P356
10.1093/HUMREP/9.SUPPL_1.40
P407
P478
P50
P577
1994-06-01T00:00:00Z